comparemela.com

Latest Breaking News On - Director nilda mesa - Page 4 : comparemela.com

Skandinaviska Enskilda Banken AB publ Sells 1,144 Shares of United Therapeutics Co (NASDAQ:UTHR)

Skandinaviska Enskilda Banken AB publ Sells 1,144 Shares of United Therapeutics Co (NASDAQ:UTHR)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Nicollet Investment Management Inc Purchases 115 Shares of United Therapeutics Co (NASDAQ:UTHR)

Nicollet Investment Management Inc. increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 2.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,788 shares of the biotechnology company’s stock after acquiring an additional 115 shares […]

Assenagon Asset Management S A Has $20 13 Million Holdings in United Therapeutics Co (NASDAQ:UTHR)

Assenagon Asset Management S.A. reduced its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 81.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 89,133 shares of the biotechnology company’s stock after selling 399,050 shares during the quarter. Assenagon Asset Management […]

United Therapeutics Co (NASDAQ:UTHR) Receives $297 88 Consensus Price Target from Brokerages

Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have been given an average recommendation of “Buy” by the eight research firms that are currently covering the stock, MarketBeat reports. Eight equities research analysts have rated the stock with a buy rating. The average 1 year price target among brokerages that have issued a […]

United Therapeutics Co (NASDAQ:UTHR) Receives Consensus Rating of Buy from Analysts

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) has been given a consensus rating of “Buy” by the eight research firms that are covering the firm, MarketBeat.com reports. Eight investment analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have covered the stock in the last […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.